46 Chapter 2 38. Ouellette JN, Drifka CR, Pointer KB, Liu Y, Lieberthal TJ, Kao WJ, Kuo JS, Loeffler AG, Eliceiri KW. Navigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer. Bioengineering 2021: 8(2). 39. Seo BR, Chen X, Ling L, Song YH, Shimpi AA, Choi S, Gonzalez J, Sapudom J, Wang K, Andresen Eguiluz RC, Gourdon D, Shenoy VB, Fischbach C. Collagen microarchitecture mechanically controls myofibroblast differentiation. Proc Natl Acad Sci USA 2020: 117(21): 11387-11398. 40. Tisler M, Alkmin S, Chang HY, Leet J, Bernau K, Sandbo N, Campagnola PJ. Analysis of fibroblast migration dynamics in idiopathic pulmonary fibrosis using image-based scaffolds of the lung extracellular matrix. Am J Physiol Lung Cell Mol Physiol 2020: 318(2): L276-L286. 41. Matera DL, Wang WY, Smith MR, Shikanov A, Baker BM. Fiber Density Modulates Cell Spreading in 3D Interstitial Matrix Mimetics. ACS Biomater Sci Eng 2019: 5(6): 2965-2975. 42. Costa DSd, Reis RL, Pashkuleva I. Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders. Annu Rev Biomed Eng 2017: 19(1): 1-26. 43. Vallet SD, Clerc O, Ricard-Blum S. Glycosaminoglycan–Protein Interactions: The First Draft of the Glycosaminoglycan Interactome. J Histochem Cytochem 2021: 69(2): 93-104. 44. Klingberg F, Chau G, Walraven M, Boo S, Koehler A, Chow ML, Olsen AL, Im M, Lodyga M, Wells RG, White ES, Hinz B. The fibronectin ED-A domain enhances recruitment of latent TGF-beta-binding protein-1 to the fibroblast matrix. J Cell Sci 2018: 131(5). 45. Klingberg F, Chow ML, Koehler A, Boo S, Buscemi L, Quinn TM, Costell M, Alman BA, Genot E, Hinz B. Prestress in the extracellular matrix sensitizes latent TGF-beta1 for activation. J Cell Biol 2014: 207(2): 283-297. 46. Liu G, Cooley MA, Jarnicki AG, Borghuis T, Nair PM, Tjin G, Hsu AC, Haw TJ, Fricker M, Harrison CL, Jones B, Hansbro NG, Wark PA, Horvat JC, Argraves WS, Oliver BG, Knight DA, Burgess JK, Hansbro PM. Fibulin-1c regulates transforming growth factor-beta activation in pulmonary tissue fibrosis. JCI Insight 2019: 5(16). 47. Jaffar J, Unger S, Corte TJ, Keller M, Wolters PJ, Richeldi L, Cerri S, Prele CM, Hansbro PM, Argraves WS, Oliver RA, Oliver BG, Black JL, Burgess JK. Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis. Chest 2014: 146(4): 1055-1063. 48. Uhl FE, Zhang F, Pouliot RA, Uriarte JJ, Rolandsson Enes S, Han X, Ouyang Y, Xia K, Westergren-Thorsson G, Malmström A, Hallgren O, Linhardt RJ, Weiss DJ. Functional role of glycosaminoglycans in decellularized lung extracellular matrix. Acta Biomater 2020: 102: 231-246. 49. Westergren-Thorsson G, Hedstrom U, Nybom A, Tykesson E, Ahrman E, Hornfelt M, Maccarana M, van Kuppevelt TH, Dellgren G, Wildt M, Zhou XH, Eriksson L, Bjermer L, Hallgren O. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2017: 83: 27-38. 50. Aumiller V, Strobel B, Romeike M, Schuler M, Stierstorfer BE, Kreuz S. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis. Sci Rep 2017: 7(1): 149.
RkJQdWJsaXNoZXIy MTk4NDMw